Your browser doesn't support javascript.
loading
Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes.
Bernstein, David I; Cardin, Rhonda D; Bravo, Fernando J; Hamouda, Tarek; Pullum, Derek A; Cohen, Gary; Bitko, Vira; Fattom, Ali.
Afiliación
  • Bernstein DI; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Electronic address: david.bernstein@cchmc.org.
  • Cardin RD; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Bravo FJ; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Hamouda T; BlueWillow Biologics, Ann Arbor, MI, USA.
  • Pullum DA; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Cohen G; University of Pennsylvania, Philadelphia, PA, USA.
  • Bitko V; BlueWillow Biologics, Ann Arbor, MI, USA.
  • Fattom A; BlueWillow Biologics, Ann Arbor, MI, USA. Electronic address: ali.fattom@bluewillow.com.
Vaccine ; 37(43): 6470-6477, 2019 10 08.
Article en En | MEDLINE | ID: mdl-31515143

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Herpes Genital / Vacunas contra el Virus del Herpes Simple / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Vaccine Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Herpes Genital / Vacunas contra el Virus del Herpes Simple / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Vaccine Año: 2019 Tipo del documento: Article